Program

THURSDAY March 6

09.00
Welcome and introduction

Frédéric Lioté (France), Fernando Perez-Ruiz (Spain)

MORNING - SESSION 1

Chairs: Leo Joosten (The Netherlands), Hang-Korng Ea (France)

Introduction to Modulation of inflammation

Leo Joosten (The Netherlands), Hang-Korng Ea (France)

Inflammation, epigenetics modulation

Stephanie FANUCCHI (The Netherlands)

Multi-omic single-cell data integration and regulatory inference in diseases

Yang Li (Germany)

Coffee break

MORNING - SESSION 2

Macrophages and atherosclerosis

Guilia CHINETTI (France)

Pain and arthritis: novel mediators

Emmanuel DEVAL (France)

CHIP and gout inflammation

Isidoro COBO (The United States)

Lunch break - Poster viewing and networking

AFTERNOON - SESSION 1

Chairs: Jessica Bertrand (Germany), Hervé Kempf (France)

Arterial calcification heterogeneity

Thibaut QUILLARD (France)

Bone formation and arterial medial calcification: how similar are they?

Isabel ORRISS (United Kingdom)

Calcified OA patients and genomics

Cindy BOER (The Netherlands)

Pathogenic role of CPP crystals

Augustin Latourte (France)

Coffee break

AFTERNOON - SESSION 2

Chairs: Fernando Perez-Ruiz (Spain)

Oral communications - session 1

New tools in calcium crystal imaging

Fabio Becce (Switzerland)

17.35
END OF THE 1ST DAY

Friday March 7

08.45
Introduction

Frédéric Lioté (France), Fernando Perez-Ruiz (Spain)

MORNING - SESSION 1

Chairs: Tania Crisan (Romania)

Discovery of Common Variants and Novel Genes Associated with Urate Levels: Insights from the CKDGen Round 5 GWAS Project

Sahar Ghasemi (Germany)

Genetics of gout in Oceania

Tristan PASCART (France)

What triggers flares?

Hang-Korng EA (France)

Coffee break

MORNING-SESSION 2

Chairs: Frédéric Lioté (France), Alexander So (Switzerland)

Environmental factors and hyperuricemia

Thomas BARDIN (France)

Renal handling of urate: role of environmental factors

Emmanuel Letavernier (France)

Oral communications - Session 2

Lunch break - Poster viewing and networking

AFTERNOON - SESSION 1

Chairs: Hang-Korng Ea (France)

Can we stop urate lowering therapy in people with gout?

Pascal RICHETTE (France)

How low is too low? Tailored goutology

Fernando PEREZ-RUIZ (Spain)

Coffee break

AFTERNOON - SESSION 2

Chairs: Frédéric Lioté (France), Fernando PEREZ-RUIZ (Spain)

Oral communications - Session 3

Low dose colchicine (or not) in preventing CV events

Michael Pillinger (The United states)

17.00
FAREWELL

Frédéric Lioté (France), Hang-Korng EA (France), Tristan Pascart (France), Fernando Perez-Ruiz (Spain)

Speakers

BARDIN Thomas (France)

BECCE Fabio (Switzerland)

BERTRAND Jessica (Germany)

BOER Cindy (The Netherlands)

CHINETTI Guilia (France)

COBO Isidoro (The United States)

CRISAN Tania (Romania)

DEVAL Emmanuel (France)

EA Hang-Korng (France)

FANUCCHI Stephanie (The Netherlands)

GHASEMI Sahar (Germany)

GUILLARD Thibault (France)

JOOSTEN Leo (The Netherlands)

KEMPF Hervé (France)

LATOURTE Augustin (France)

LETAVERNIER Emmanuel (France)

LI Yang (Germany)

LIOTé Frédéric (France)

ORRISS Isabel (United Kingdom)

PASCART Tristan (France)

PEREZ-RUIZ Fernando (Spain)

PILLINGER Michael (The United states)

RICHETTE Pascal (France)

SO Alexander (Switzerland)

Program

THURSDAY March 6

09.00

Welcome and introduction

MORNING - SESSION 1

Introduction to Modulation of inflammation

Inflammation, epigenetics modulation

Multi-omic single-cell data integration and regulatory inference in diseases

Coffee break

MORNING - SESSION 2

Macrophages and atherosclerosis

Pain and arthritis: novel mediators

CHIP and gout inflammation

Lunch break - Poster viewing and networking

AFTERNOON - SESSION 1

Arterial calcification heterogeneity

Bone formation and arterial medial calcification: how similar are they?

Calcified OA patients and genomics

Pathogenic role of CPP crystals

Coffee break

AFTERNOON - SESSION 2

Oral communications - session 1

New tools in calcium crystal imaging

17.35

END OF THE 1ST DAY

Friday March 7

08.45

Introduction

MORNING - SESSION 1

Discovery of Common Variants and Novel Genes Associated with Urate Levels: Insights from the CKDGen Round 5 GWAS Project

Genetics of gout in Oceania

What triggers flares?

Coffee break

MORNING-SESSION 2

Environmental factors and hyperuricemia

Renal handling of urate: role of environmental factors

Oral communications - Session 2

Lunch break - Poster viewing and networking

AFTERNOON - SESSION 1

Can we stop urate lowering therapy in people with gout?

How low is too low? Tailored goutology

Coffee break

AFTERNOON - SESSION 2

Oral communications - Session 3

Low dose colchicine (or not) in preventing CV events

17.00

FAREWELL

Speakers